Text: H.R.6312 — 112th Congress (2011-2012)All Bill Information (Except Text)

There is one version of the bill.

Text available as:

Shown Here:
Introduced in House (08/02/2012)


112th CONGRESS
2d Session
H. R. 6312

To amend the Controlled Substances Act to place certain synthetic drugs in Schedule I.


IN THE HOUSE OF REPRESENTATIVES
August 2, 2012

Mrs. Emerson introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned


A BILL

To amend the Controlled Substances Act to place certain synthetic drugs in Schedule I.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Synthetic Cathinones Control Act of 2012”.

SEC. 2. Addition of synthetic drugs to schedule i of the controlled substances act.

Schedule I of section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) is amended in subsection (c) by adding at the end the following:

“(29) 3,4-methylenedioxymethcathinone (methylone).

“(30) Naphthylpyrovalerone (naphyrone).

“(31) 4-fluoromethcathinone (flephedrone).

“(32) 4-methoxymethcathinone (methedrone; Bk–PMMA).

“(33) Ethcathinone (N-ethylcathinone).

“(34) 3,4-methylenedioxyethcathinone (ethylone).

“(35) Beta-keto-N-methyl-3,4-benzodioxyolybutanamine (butylone).

“(36) N,N-dimethylcathinone (metamfepramone).

“(37) Alpha-pyrrolidinopropiophenone (alpha-PPP).

“(38) 4-methoxy-alphapyrrolidinopropiophenone (MOPPP).

“(39) 3,4-methylenedioxyalphapyrrolidinopropiophenone (MDPPP).

“(40) Alpha-pyrrolidinovalerophenone (alpha-PVP).

“(41) 6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-6-amine (MDAI).

“(42) 3-fluoromethcathinone.

“(43) 4′-methyl-α-pyrrolidinobutiophenone (MPBP).”.